Patent application number | Description | Published |
20080279880 | PEPTIDE VACCINES AGAINST GROUP A STREPTOCOCCI - This invention, in one aspect, relates to synthetic immunoreactive peptides. These peptides are approximately 20-25 amino acids in length which are portions of the N termini of the M proteins of the most prevalent United States (U.S.) Group A | 11-13-2008 |
20110110969 | PEPTIDE VACCINES AGAINST GROUP A STREPTOCOCCI - This invention, in one aspect, relates to synthetic immunoreactive peptides. These peptides are approximately 20-25 amino acids in length which are portions of the N termini of the M proteins of the most prevalent United States (U.S.) Group A | 05-12-2011 |
20120177685 | PEPTIDE VACCINES AGAINST GROUP A STREPTOCOCCI - This invention, in one aspect, relates to synthetic immunoreactive peptides. These peptides are approximately 20-25 amino acids in length which are portions of the N termini of the M proteins of the most prevalent United States (U.S.) Group A | 07-12-2012 |
20130202635 | PEPTIDE VACCINES AGAINST GROUP A STREPTOCOCCI - This invention, in one aspect, relates to synthetic immunoreactive peptides. These peptides are approximately 20-25 amino acids in length which are portions of the N termini of the M proteins of the most prevalent United States (U.S.) Group A | 08-08-2013 |
Patent application number | Description | Published |
20090075891 | Methods and dressings for sealing internal injuries - Disclosed are solid and frozen haemostatic materials and dressings consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings. | 03-19-2009 |
20110196421 | METHODS AND DRESSINGS FOR SEALING INTERNAL INJURIES - Disclosed are solid and frozen haemostatic materials and dressings consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings. | 08-11-2011 |
20120148658 | SOLID DRESSING FOR TREATING WOUNDED TISSUE - Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of fibrinogen and a fibrinogen activator, wherein the fibrinogen is present in an amount between 3.0 mg/cm | 06-14-2012 |
20120148659 | SOLID DRESSING FOR TREATING WOUNDED TISSUE - Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of a fibrinogen component and a fibrinogen activator, wherein the haemostatic layer(s) is cast or formed from a single aqueous solution containing the fibrinogen component and the fibrinogen activator. Also disclosed are methods for treating wounded tissue using these dressings and frozen compositions useful for preparing the haemostatic layer(s) of these dressings. | 06-14-2012 |
20120150087 | SOLID DRESSING FOR TREATING WOUNDED TISSUE - Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of a fibrinogen component and thrombin, wherein the thrombin is present in an amount between 0.250 Units/mg of fibrinogen component and 0.062 Units/mg of fibrinogen component. Also disclosed are methods for treating wounded tissue. | 06-14-2012 |
20120321692 | Methods and Dressings for Sealing Internal Injuries - Disclosed are solid and frozen haemostatic materials and dressings consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings. | 12-20-2012 |
20150118284 | SOLID DRESSING FOR TREATING WOUNDED TISSUE - Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of a fibrinogen component and thrombin, wherein the thrombin is present in an amount between 0.250 Units/mg of fibrinogen component and 0.062 Units/mg of fibrinogen component. Also disclosed are methods for treating wounded tissue. | 04-30-2015 |
20150132363 | SOLID DRESSING FOR TREATING WOUNDED TISSUE - Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of fibrinogen and a fibrinogen activator, wherein the fibrinogen is present in an amount between 3.0 mg/cm | 05-14-2015 |
20150283288 | SOLID DRESSING FOR TREATING WOUNDED TISSUE - Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of a fibrinogen component and a fibrinogen activator, wherein the haemostatic layer(s) is cast or formed from a single aqueous solution containing the fibrinogen component and the fibrinogen activator. Also disclosed are methods for treating wounded tissue using these dressings and frozen compositions useful for preparing the haemostatic layer(s) of these dressings. | 10-08-2015 |
20150352245 | METHODS AND DRESSINGS FOR SEALING INTERNAL INJURIES - Disclosed are solid and frozen haemostatic materials and dressings consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings. | 12-10-2015 |
Patent application number | Description | Published |
20130287837 | SOLID DRESSING FOR TREATING WOUNDED TISSUE - Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of a fibrinogen component and a fibrinogen activator, wherein the haemostatic layer(s) is cast or formed from a single aqueous solution containing the fibrinogen component and the fibrinogen activator. Also disclosed are methods for treating wounded tissue using these dressings and frozen compositions useful for preparing the haemostatic layer(s) of these dressings. | 10-31-2013 |
20150289861 | DEVICES FOR USE WITH HEMOSTATIC MATERIALS - Disclosed are solid and frozen haemostatic materials and dressings consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings, particularly for the treatment of injured tissue via endoscopic or minimally-invasive surgical techniques. | 10-15-2015 |
20150328053 | SOLID DRESSING FOR TREATING WOUNDED TISSUE - Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of a fibrinogen component and a fibrinogen activator, wherein the haemostatic layer(s) is cast or formed from a single aqueous solution containing the fibrinogen component and the fibrinogen activator. Also disclosed are methods for treating wounded tissue using these dressings and frozen compositions useful for preparing the haemostatic layer(s) of these dressings. | 11-19-2015 |
20150367019 | HEMOSTATIC COMPOSITIONS AND METHODS - Disclosed are solid and frozen haemostatic materials and dressings consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings, particularly for the treatment of injured tissue via endoscopic or minimally-invasive surgical techniques. | 12-24-2015 |
20160022861 | COMPOSITIONS HAVING ABSORBABLE MATERIALS, METHODS, AND APPLICATORS FOR SEALING INJURIES - Disclosed are solid and frozen haemostatic materials utilizing an absorbable scaffolding material and consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings, particularly for the treatment of injured tissue via endoscopic or minimally-invasive surgical techniques. | 01-28-2016 |
20160038347 | COMPOSITIONS HAVING CYLINDRICAL VOLUME, METHODS, AND APPLICATORS FOR SEALING INJURIES - Disclosed are solid and frozen haemostatic materials having a rod shape and suitable applicators and plungers for application of such dressings to wounded tissue wherein said dressings consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings, particularly for the treatment of injured tissue via endoscopic or minimally-invasive surgical techniques. | 02-11-2016 |
20160106883 | Processes For Mixing Fibrinogen and Thrombin Under Conditions That MinimizeFibrin Formation While Preserving Fibrin-forming Ability, Compositions Producedby These Processes, and the Use Thereof - Fibrin Sealant products are used for topical hemostasis and tissue adherence. They are composed of two main reagents, fibrinogen and thrombin. When mixed in solution fibrinogen is converted to fibrin upon the addition of activated thrombin. Therefore typically these two components are stored separately in a lyophilized or liquid state, and mixed, upon or immediately before, application to a patient. While effective, these products require significant preparation that must take place immediately before application, thus delaying treatment and limiting the use of these haemostatic products to the treatment of mild forms of low pressure and low volume bleeding. Attempts to eliminate this delay and expand the usefulness and effectiveness of these products have resulted in products produced by processes that require the separation of these components and their deposition in distinct layers within the product. The processes described herein permit the mixing of fibrinogen and thrombin during product manufacture, without excessive fibrin formation. The resulting ‘pre-mixed’ fibrin sealant material can then be stored in either a frozen or dried state, or suspended in a non-aqueous environment. Activation of the material to form therapeutic fibrin sealant is accomplished by permitting the product to thaw (if frozen) or by the addition of water or other aqueous fluid, including blood, or other bodily fluids, if dried or suspended in a non-aqueous environment. The resulting material can be used to make a product in which a pre-mixed form of activatable fibrin sealant is a desired component. | 04-21-2016 |
Patent application number | Description | Published |
20120126529 | Roofing Composition - A split-flashing composition for covering a protrusion from a roof, the composition having a flange portion adapted for sealing to a roof surface, the flange portion being substantially planar and having an in-plane spiral shape that describes a closed-loop opening for receiving the protrusion; the flange portion having first and second flange end portions that are connected to each other in-plane and in an off-set manner; a collar portion fixably attached to the flange portion; a closed-loop collar-portion construction having a substantially curved wall section and a substantially planar wall section that are connected to each other and together define an internal volume of space, wherein the substantially curved wall section spirals outwardly from a first substantially curved wall section edge portion to a second substantially curved wall section edge portion; the collar portion having a substantially conical shape, wherein the cross-sectional area of the internal volume of space decreases as the distance between the flange portion and the cross-sectional area increases, the cross-sectional area being in a plane that is substantially perpendicular to a collar-portion longitudinal axis; and the collar portion having a substantially planar wall section that is substantially perpendicular to both a first substantially curved wall section edge portion and a second substantially curved wall section edge portion. | 05-24-2012 |
20120267052 | ROOFING APPARATUS - An apparatus for welding a synthetic strip to a roofing membrane that is attached to a roofing construct, the synthetic strip having a central raised portion that extends along the longitudinal length of the synthetic strip, the synthetic strip having flanges extending widthwise from the central raised portion, and the synthetic strip having a substantially planar underside portion, the apparatus having a self-propelled housing having a drive wheel for movably supporting the housing on the membrane; a first guide-wheel element mounted to the housing and positioned in or underneath the housing and the first guide-wheel element having a peripheral channel adapted to engage and receive the underside flat-planar portion of the synthetic strip and guide the synthetic strip, wherein the guide-wheel receiving channel has a channel width adapted to receive the total width of the synthetic strip. | 10-25-2012 |
20140159359 | ROOFING COMPOSITION - A split-flashing composition for covering a protrusion from a roof, having a flange for sealing to a roof surface with an in-plane spiral closed-loop opening with first and second end portions connected together in an off-set manner, and a generally conical collar portion that extends from the flange portion, the collar portion having a curved wall section and a planar wall section that define an internal volume within the collar portion. | 06-12-2014 |
20140215963 | COMPOSITE ROOF SYSTEMS AND METHODS OF INSTALLATION - A roofing system, assembly and related methods of manufacture and installation for simulating a metal roof includes a membrane which is installed over a roof deck and aesthetic ribs installed directly on the membrane layer using a hot melt adhesive having a melting temperature below the melting temperature of the membrane. | 08-07-2014 |
20150315791 | COMPOSITE ROOF SYSTEMS AND METHODS OF INSTALLATION - A roofing system, assembly and related methods of manufacture and installation for simulating a metal roof includes a membrane which is installed over a roof deck and aesthetic ribs installed directly on the membrane layer. | 11-05-2015 |
Patent application number | Description | Published |
20080203026 | Reverse Osmosis Filtration System Storage Tanks - A reverse osmosis product water storage tank having first and second molded shells coupled together to form an enclosure, a bladder within the enclosure and coupled to separate product water from squeeze water within the enclosure, a first port through a wall of the enclosure to provide water access to the product water side of the bladder, a second port through a wall of the enclosure to provide squeeze water access to the squeeze water side of the bladder and wherein the inner surfaces of the enclosure having a topography configured to define a plurality of channels between the inner surfaces of the enclosure and the bladder when the bladder is full of product water for accommodating squeeze water flow into the enclosure between the enclosure and the bladder when the bladder is full of product water. | 08-28-2008 |
20100024893 | Reverse Osmosis Filtration Systems - Reverse osmosis filtration systems that are self contained and easily converted from above the counter use to below the counter use. The systems feature a simple construction, including a two piece manifold assembly to which filters, including a reverse osmosis filter, a product water storage tank and a control valve connect, all without separate fasteners. The manifold assembly provides all water connections within the system, and includes connections to connect to a water supply, a drain, two dispensers and to an auxiliary water storage tank. The system pressurizes squeeze water for product water dispensing, providing maximum efficiency, maximum storage capacity for a given tank size and maximum pressure for dispensing product water. Various embodiments are disclosed. | 02-04-2010 |